Inhibition of human immunodeficiency virus type-1 (HIV-1) replication at a reverse transcription step by human cell factor(s)

被引:2
|
作者
Tempaku, A [1 ]
机构
[1] Univ Fukui, Fac Med Sci, Sch Med, Fukui 9101193, Japan
关键词
human immunodeficiency virus type-1 (HIV-1); reverse transcriptase; host factor;
D O I
10.1248/bpb.28.893
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Infection of human cell with human immunodeficiency virus type-1 (HIV-1) was suppressed by cellular genetic factor(s) at reverse transcription step. Although same amount of virus adsorbed on both cells, small amount of HIV-1 (11113 strain) infected HeLa (MAGI/CCR5) cell, while large amount of RIV-1 infected HOS (GHOST/CXCR4) cell. Regulation of virus replication at postentry level by cellular factor(s) had an important role for low efficiency of RIV-1 infection to MAGI/CCR5 cell. Provirus DNA formation in MAGI/CCR5 cell was less efficient than in GHOST/CXCR4 cell. Once GHOST/CXCR4 cell was fused with MAGI/CCR5 cell, susceptibility against HIV-1 decreased. Further, HIV-1 reverse transcriptase (RT) activity was strongly inhibited by cytosolic protein, derived from MAGI/CCR5 cell, in vitro. This research cleared a certain human cell genetically carries some factor(s) which inhibits the activity of HIV-1 RT.
引用
收藏
页码:893 / 897
页数:5
相关论文
共 50 条
  • [21] Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection
    Ohshiro, Y
    Murakami, T
    Matsuda, K
    Nishioka, K
    Yoshida, K
    Yamamoto, N
    MICROBIOLOGY AND IMMUNOLOGY, 1996, 40 (11) : 827 - 835
  • [22] ANTIRETROVIRAL THERAPY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION
    EMERY, S
    COOPER, DA
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1995, 25 (04): : 344 - 349
  • [23] PRODUCTIVE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION OF NONPROLIFERATING HUMAN MONOCYTES
    WEINBERG, JB
    MATTHEWS, TJ
    CULLEN, BR
    MALIM, MH
    JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (06): : 1477 - 1482
  • [24] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 NEF INCREASES THE EFFICIENCY OF REVERSE TRANSCRIPTION IN THE INFECTED CELL
    SCHWARTZ, O
    MARECHAL, V
    DANOS, O
    HEARD, JM
    JOURNAL OF VIROLOGY, 1995, 69 (07) : 4053 - 4059
  • [25] Inhibition of human immunodeficiency virus type (HIV-1) replication by some diversely functionalized spirocyclopropyl derivatives
    Witvrouw, M
    Pannecouque, C
    De Clercq, E
    Fernández-Alvarez, E
    Marco, JL
    ARCHIV DER PHARMAZIE, 1999, 332 (05) : 163 - 166
  • [26] A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) INFECTION-ENHANCING FACTOR IN SEROPOSITIVE SERA
    ROBINSON, WE
    MONTEFIORI, DC
    MITCHELL, WM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 149 (02) : 693 - 699
  • [27] PLASMID LIBRARY FOR THE TRANSCRIPTION OF RNA PROBES COMPLEMENTARY TO THE ENTIRE GENOME OF THE HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 (HIV-1)
    ROY, C
    KNAAK, C
    GARVIE, P
    LIMMER, B
    CAMPIONEPICCARDO, J
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 1989, 67 (09): : 510 - 515
  • [28] An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication
    An, DS
    Morizono, K
    Li, QX
    Mao, SH
    Lu, S
    Chen, ISY
    JOURNAL OF VIROLOGY, 1999, 73 (09) : 7671 - 7677
  • [29] SELECTIVE-INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 REPLICATION BY THE (-) BUT NOT THE (+) ENANTIOMER OF GOSSYPOL
    LIN, TS
    SCHINAZI, R
    GRIFFITH, BP
    AUGUST, EM
    ERIKSSON, BFH
    ZHENG, DK
    HUANG, L
    PRUSOFF, WH
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (12) : 2149 - 2151
  • [30] RESISTANCE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) TO NONNUCLEOSIDE HIV-1-SPECIFIC REVERSE-TRANSCRIPTASE INHIBITORS
    DECLERCQ, E
    INTERNATIONAL JOURNAL OF IMMUNOTHERAPY, 1994, 10 (04): : 145 - 158